|
|
|
Sigma-Aldrich,
Corporation,
with headquarters in St. Louis, Missouri, is a leading Life Science and
High Technology company. Our biochemical and organic chemical products
and kits are used in scientific and genomic research, biotechnology,
pharmaceutical development, the diagnosis of disease and as key
components in pharmaceutical and other high technology manufacturing. We
have customers in life science companies, university and government
institutions, hospitals and in industry. Over one million scientists and
technologists use our products. Sigma-Aldrich operates in 35 countries
and has over 6,800 employees providing excellent service worldwide. We
are committed to accelerating Customers' success through leadership in
Life Science, High Technology and Service.
|
|
|
|
DETAILS |
|
|
Index |
S&P 500; S&P 1500
Composite; Nasdaq 100 |
|
Sector |
Basic Materials |
|
Industry |
Specialty Chemicals |
|
URLs |
|
| Ticker |
(NASDAQ: SIAL) |
| Founded |
|
| |
|
| Linked to |
|
| |
|
| |
|
| |
|
|
|
| |
|
HISTORY |
Divestiture |
|
Dec 19, 2002 |
Facility
in Milwaukee sold to Wisconsin's Department of Transportation (WISDOT)
$32.5 million in cash. |
|
Nov 22, 2002 |
Sold
its key special chemistry and cardiac ("Chemistry") products to
Trinity Biotech plc (Nasdaq: TRIB). Terms of the sale were not
disclosed. |
|
Aug 27, 2002 |
Completed
the sale of its Coagulation product line to Trinity Biotech plc
(Nasdaq: TRIB). |
|
May 15, 2002 |
Sold
its enzyme immunoassay (EIA) diagnostic product line to IVAX
Diagnostics, Inc. (AMEX: IVD). Terms of the transaction were not
disclosed. |
|
Mar 27, 2000 |
Sold its B-Line
Systems business to Cooper Industries, Inc. (NYSE: CBE) for $425
million. |
|
|
|
|
HISTORY |
Acquisitions |
|
Apr 1, 2005 |
Proligo Group (Proligo)
from Degussa AG (Frankfurt: DGXG.DE). Terms of the proposed
purchase were not disclosed. |
|
Feb 28, 2005 |
JRH Biosciences
division (JRH) of CSL Limited for $370 million in cash |
|
Jun 22, 2004 |
Tetrionics |
|
Apr 14, 2004 |
Ultrafine |
Linked to: 3i Group; Renaissance Ventures LP |
|
Feb 16, 2001 |
Isotec, Inc.
$35.6 million was paid in cash. |
|
Aug 1, 2000 |
Amelung GmbH of
Lemgo, Germany. Sigma-Aldrich acquired all of the stock of
Amelung for $28 million, which includes an initial cash payment
of $25 million and assumed debt of $3 million. A payment of up
to an additional $6 million may be made in mid-2003 if there
have been no adverse impacts against the sellers’
representations by that time. |
|
Jul 24, 2000 |
First Medical, Inc. Sigma-Aldrich's initial investment is $15
million, with additional payments of up to $40 million to
current owners if certain contingent sales and income growth
targets are met through 2005. |
|
|
ARK
Scientific GmbH Biosystems, Germany. |
|
Mar 31, 1999 |
Acquisition
of a 25% interest in RdH Laborchemikalien GmbH & Co. KG, a
partnership located in Seelze, Germany that produces laboratory
chemicals under the Riedel-de Haën brand name. With this
acquisition, Sigma-Aldrich now owns 100% of the partnership. The
partnership was formed in June, 1997 with Riedel-de Haën, GmbH
owning a 25% interest and Sigma-Aldrich owning 75%. |
|
Dec 23, 1998 |
Genosys Biotechnologies.
Sigma-Aldrich
acquired all of the outstanding securities of Genosys for $39.5
million cash. | Linked to: BCM Technologies (Baylor College of
Medicine) |
|
Jun 16, 1997 |
Finalized
a new laboratory chemicals partnership in Germany with
AlliedSignal Inc.(NYSE: ALD). The Sigma-Aldrich/AlliedSignal
partnership, known as RdH Laborchemikalien GmbH & Co., KG
comprises the former laboratory chemicals business of
AlliedSignal Specialty Chemicals' Riedel-de Haën unit, based in
Seelze near Hannover. Sigma-Aldrich and AlliedSignal will own
75% and 25% of the partnership, respectively. The other terms of
the partnership were not disclosed. The rest of the Riedel-de
Haën specialty chemical business will continue to be owned and
operated by AlliedSignal. |
|
|
|
|
|
|
|
|
|
|
|
|
